Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Infections Post Transplant

Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts

Abstract

Patients undergoing bone marrow transplantation are profoundly immunosuppressed as a result of their intensive myeloablative chemotherapy and are at high risk for opportunistic fungal infections mainly caused by Candida spp and Aspergillus spp. Trichosporon beigelii (T beigelii) has emerged as a life-threatening opportunistic pathogen in granulocytopenic and immunocompromised hosts and there is a marked increase in cases reported in the literature. Response to antifungal agents is poor, mortality is high and immunological recovery is the most important factor for a favorable outcome in patients with trichosporonosis. We present three cases of T. beigelii infection in patients undergoing allogeneic bone marrow transplantation in our center and we review cases described in the literature. Bone Marrow Transplantation (2000) 25, 745–749.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Rippon JW . Superficial infections. In: Rippon JW (ed) Medical Mycology 2nd edn: WB Saunders: Philadelphia 1979 pp 148–151

    Google Scholar 

  2. Hoy J, Hsu KC, Rolston K et al. Trichosporon beigelii infection: a review Rev Infect Dis 1986 8: 959–967

    Article  CAS  Google Scholar 

  3. Yoss BS, Sautter RL, Brenker HJ . Trichosporon beigelii, a new neonatal pathogen Am J Perinatol 1997 14: 113–117

    Article  CAS  Google Scholar 

  4. Keay S, Denning DW, Stevens DA . Endocarditis due to Trichosporon beigelii: in vitro susceptibility of isolates and review Rev Infect Dis 1991 13: 383–386

    Article  CAS  Google Scholar 

  5. Brahn E, Leonard PA . Trichosporon cutaneum endocarditis: a sequela of intravenous drug-abuse Am J Clin Path 1982 78: 792–794

    Article  CAS  Google Scholar 

  6. Ashpole RD, Jacobson K, King AT, Holmes AE . Cysto-peritoneal shunt infection with Trichosporon beigelii Br JNeurosurg 1991 5: 515–517

    Article  CAS  Google Scholar 

  7. Muramatsu H, Kume H, Hojo M et al. A case of Trichosporon beigelii peritonitis in CAPD Kansenshogaku Zasshi 1992 66: 1129–1132

    Article  CAS  Google Scholar 

  8. Mathews MS, Prabhakar S . Chronic meningitis caused by Trichosporon beigelii in India Mycoses 1995 38: 125–126

    Article  CAS  Google Scholar 

  9. Bottari M, D'Amore F, Buda CA et al. Stenosing esophagitis caused by Trichosporon beigelii: presentation of a rare case G Chir 1997 18: 344–347

    CAS  PubMed  Google Scholar 

  10. Sheikh HA, Mahgoub S, Badi K . Postoperative endophthalmitis due to Trichosporon cutaneum Br J Ophthalmol 1974 58: 591–594

    Article  CAS  Google Scholar 

  11. Gardella S, Nomdedeu B, Bombi JA et al. Fatal fungemia with arthritic involvement caused by Trichosporon beigelii in a bone marrow transplant recipient J Infect Dis 1985 151: 566

    Article  CAS  Google Scholar 

  12. Patel SA, Borges MC, Batt MD, Rosenblate JH . Trichosporon cholangitis associated with hyperbilirubinemia and findings suggesting primary sclerosing cholangitis on endoscopic retrograde cholangiopancreatography Am J Gastroenterol 1990 85: 84–87

    CAS  PubMed  Google Scholar 

  13. Korinek JK, Guarda LA, Bolivar R, Stroehlein JR . Trichosporon hepatitis Gastroenterology 1983 85: 732–734

    CAS  PubMed  Google Scholar 

  14. Nishiura Y, Nakagawa-Yoshida K, Suga M et al. Assignment and serotyping of Trichosporon species: the causative agents of summer-type hypersensitivity pneumonitis J Med Vet Mycol 1997 35: 45–52

    Article  CAS  Google Scholar 

  15. McBride ME, Kalter DC, Wolf JE Jr . Antifungal susceptibility testing of Trichosporon beigelii to imidazole compounds Can J Microbiol 1988 34: 850–854

    Article  CAS  Google Scholar 

  16. Walsh TJ, Melcher GP, Rinaldi MG et al. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B J Clin Microbiol 1990 28: 1612–1622

    Google Scholar 

  17. Nasu K, Akuzuki S, Yoshiyama K et al. Disseminated Trichosporon infection. A case report and immunohistochemical study Arch Pathol Lab Med 1994 118: 191–194

    CAS  PubMed  Google Scholar 

  18. Muranaka H, Suga M, Nakagawa K et al. Effects of granulocyte and granuloyte–macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis Infect Immun 1997 65: 3422–3429

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Lucarelli G, Galimberti M, Polchi P et al. Bone marrow transplantation in patients with thalassemia New Engl J Med 1990 322: 417–421

    Article  CAS  Google Scholar 

  20. Goodman JL, Winston DJ, Greenfield RA et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation New Engl J Med 1992 326: 845–851

    Article  CAS  Google Scholar 

  21. Slavin MA, Osborne B, Adams R et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation – a prospective, randomized, double-blind study J Infect Dis 1995 171: 1545–1552

    Article  CAS  Google Scholar 

  22. Ellis ME, Clink H, Ernst P et al. Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients Eur J Clin Microbiol Infect Dis 1994 13: 3–11

    Article  CAS  Google Scholar 

  23. O'Donnell MR, Schmidt GM, Tegtmeier BR et al. Prediction of systemic fungal infection in allogeneic marrow recipients. Impact of amphotericin prophylaxis in high-risk patients J Clin Oncol 1994 12: 827–834

    Article  CAS  Google Scholar 

  24. Jesse L, Goodman MD, Drew J et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation New Engl J Med 1992 326: 845–851

    Article  Google Scholar 

  25. Perfect JR, Schell WA . The new fungal opportunists are coming Clin Infect Dis 1996 22: (Suppl. 2) S112–S118

    Article  Google Scholar 

  26. Watson KC, Kallichurum S . Brain abscess due to Trichosporon cutaneum J Med Microbiol 1970 3: 191–193

    Article  CAS  Google Scholar 

  27. Martinez LJ, Mana J, Niubo R et al. Long-term survival of a patient with prosthetic valve endocarditis due to Trichosporon beigelii Eur J Clin Microbiol Infect Dis 1991 10: 756–758

    Article  Google Scholar 

  28. Reinhart HH, Urbanski DM, Harrington SD, Sobel JD . Prosthetic valve endocarditis caused by Trichosporon beigelii Am J Med 1988 84: 355–358

    Article  CAS  Google Scholar 

  29. McManus EJ, Jones JM . Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection J Clin Microbiol 1985 21: 681–685

    CAS  PubMed  PubMed Central  Google Scholar 

  30. McManus EJ, Bozdech MJ, Jones JM . Role of the latex agglutination test for cryptococcal antigen in diagnosing disseminated infections with Trichosporon beigelii J Infect Dis 1985 151: 1167–1169

    Article  CAS  Google Scholar 

  31. Melcher GP, Reed KD, Rinaldi MG et al. Demonstration of a cell wall antigen cross-reacting with cryptococcal polysaccharide in experimental disseminated trichosporonosis J Clin Microbiol 1991 29: 192–196

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Anaissie E, Gokaslan A, Hachem R et al. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy of murine infection, and review Clin Infect Dis 1992 15: 781–787

    Article  CAS  Google Scholar 

  33. Perparim K, Nagai H, Hashimoto A et al. In vitro susceptibility of Trichosporon beigelii to antifungal agents J Chemother 1996 8: 445–448

    Article  CAS  Google Scholar 

  34. Espinel Ingroff A . In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens J Clin Microbiol 1988 36: 198–202

    Google Scholar 

  35. Sutton DA, Sanche SE, Revankar SG et al. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head–head comparison to voriconazole J Clin Microbiol 1999 37: 2343–2345

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Marco F, Pfaller MA, Messer SA, Jones RN . Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents against clinical isolates of filamentous fungi Med Mycol 1998 36: 433–436

    Article  CAS  Google Scholar 

  37. Wildfeuer A, Seidl HP, Paole I, Haberreiter A . In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin Mycoses 1998 41: 309–319

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank Ms Aileen Law, a member of our nursing staff, for excellent assistance.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erer, B., Galimberti, M., Lucarelli, G. et al. Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts. Bone Marrow Transplant 25, 745–749 (2000). https://doi.org/10.1038/sj.bmt.1702231

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702231

Keywords

This article is cited by

Search

Quick links